1. CMU Intellectual Repository

Browsing by Author Patcharaphan Sugandhavesa

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)
1-Dec-2016Association of cytologic grade of anal “Pap” smears with viral loads of human papillomavirus types 16, 18, and 52 detected in the same specimens from men who have sex with menUtaiwan Utaipat; Sumalee Siriaunkgul; Taweewat Supindham; Pongpun Saokhieo; Butsayarat Chaidaeng; Antika Wongthanee; Jongkolnee Settakorn; Kornkanok Sukpan; Darin Ruanpeng; Natthapol Kosashunhanan; Nuntisa Chotirosniramit; Patcharaphan Sugandhavesa; Toshiyuki Miura; Suwat Chariyalertsak
26-Feb-2015C-Reactive Protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settingsMark W. Tenforde; Nikhil Gupte; David W. Dowdy; David M. Asmuth; Ashwin Balagopal; Richard B. Pollard; Patcharaphan Sugandhavesa; Javier R. Lama; Sandy Pillay; Sandra W. Cardoso; Jyoti Pawar; Breno Santos; Cynthia Riviere; Noluthando Mwelase; Cecilia Kanyama; Johnstone Kumwenda; James G. Hakim; Nagalingeswaran Kumarasamy; Robert Bollinger; Richard D. Semba; Thomas B. Campbell; Amita Gupta
21-Apr-2014Change in vitamin D levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settingsFiona P. Havers; Barbara Detrick; Sandra W. Cardoso; Sima Berendes; Javier R. Lama; Patcharaphan Sugandhavesa; Noluthando H. Mwelase; Thomas B. Campbell; Amita Gupta
1-Jun-2022Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapyClaudia Hawkins; Minhee Kang; Debika Bhattacharya; Gavin Cloherty; Mary Kuhns; Roy Matining; Chloe Thio; Wadzanai Samaneka; Lameck Chinula; Nyirenda Mulinda; Sharlaa Badal-Faesen; Patcharaphan Sugandhavesa; Javier Lama; Simani Gaseitsiwe; Vera Holzmayer; Mark Anderson; Robert Murphy; Marion Peters
1-Dec-2012Immune response to 2009 H1N1 vaccine in HIV-infected adults in Northern ThailandNuntisa Chotirosniramit; Patcharaphan Sugandhavesa; Linda Aurpibul; Sunida Thetket; Natthapol Kosashunhanan; Taweewat Supindham; Panuwat Wongkulab; Quanhathai Kaewpoowat; Kanokporn Chaiklang; Oranitcha Kaewthip; Piyathida Sroysuwan; Antika Wongthanee; Hatairat Lerdsamran; Pilaipan Puthavathana; Khuanchai Suparatpinyo
1-Apr-2020Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trialPunnee Pitisuttithum; Sorachai Nitayaphan; Suwat Chariyalertsak; Jaranit Kaewkungwal; Peter Dawson; Jittima Dhitavat; Benjaluck Phonrat; Siriwat Akapirat; Nicos Karasavvas; Lindsay Wieczorek; Victoria Polonis; Michael A. Eller; Poonam Pegu; Dohoon Kim; Alexandra Schuetz; Surat Jongrakthaitae; Yingjun Zhou; Faruk Sinangil; Sanjay Phogat; Carlos A. Diazgranados; James Tartaglia; Elizabeth Heger; Kirsten Smith; Nelson L. Michael; Jean Louis Excler; Merlin L. Robb; Jerome H. Kim; Robert J. O'Connell; Sandhya Vasan; Arom Pitisuthitham; Yupa Sabmee; Narongrid Sirisopana; Chirapa Eamsila; Prapaporn Savaraj; Wanlaya Labwech; Siriluck Teerachia; Nuntisa Chotirosniramit; Taweewat Supindham; Boonlure Pruenglampoo; Patcharaphan Sugandhavesa; Natthapol Kosashunhanan; Oranitcha Kaewthip; Piyathida Sroysuwan; Pawinee Jarujareet; Silvia Ratto-Kim; Sebastian Molnar; Jesse Schoen; Nampueng Churikanont; Saowanit Getchalarat; Nongluck Sangnoi; Bessara Nuntapinit; Anant Phramtong; Pornsuk V. Grandin; Sirinan Madnote; Surawach Rittiroongrad; Boot Kaewboon; Rapee Trichavaroj; Jiraporn Puangkaew; Somsak Chantakulkij; Phiromrat Rakyat; Pornchanok Panjapornsuk; Nipattra Tragonlugsana; Weerawan Chuenarom; Mark de Souza; Viseth Ngauy; Nittaya Phanuphak; Nitiya Chomchey; Puttachard Saengtawan; Nipat Teeratakulpisarn; Rungsun Rerknimitr; Eugene Kroon; Carter A. Lee; Suchada Chinaworapong
1-Jan-2015Low expression of activation marker cd69 and chemokine receptors ccr5 and cxcr3 on memory t cells after 2009 h1n1 influenza a antigen stimulation in vitro following h1n1 vaccination of hiv-infected individualsKriangkrai Chawansuntati; Nuntisa Chotirosniramit; Patcharaphan Sugandhavesa; Linda Aurpibul; Sunida Thetket; Natthapol Kosashunhanan; Taweewat Supindham; Oranitcha Kaewthip; Piyathida Sroysuwan; Thira Sirisanthana; Khuanchai Suparatpinyo; Jiraprapa Wipasa
1-May-2017Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm<sup>3</sup>Judith S. Currier; Paula Britto; Risa M. Hoffman; Sean Brummel; Gaerolwe Masheto; Esau Joao; Breno Santos; Linda Aurpibul; Marcelo Losso; Marie F. Pierre; Adriana Weinberg; Devasena Gnanashanmugam; Nahida Chakhtoura; Karin Klingman; Renee Browning; Anne Coletti; Lynne Mofenson; David Shapiro; Jose Pilotto; Manuela Bullo; Silvina Ivalo; Anthony Ogwu; Tebogo Kakhu; Aida Asmelash; Ayotunde Omoz-Oarhe; Cristina Hofer; Elizabeth MacHado; Jacqueline Menezes; Leon Claude Sidi; Jorge Pinto; Flavia Ferreira; Geraldo Duarte; Conrado Milani Coutinho; Rosa Dea Sperhacke; Silvia Mariani Costamilan; Luis Eduardo Fernandes; Luiz Felipe Mpreira; Regis Kreitchmann; Debora Fernandes Coelho; Marineide Goncalves De Melo; Rita De Cassia Alves Lira; Linda Aristhomene; Jerry Bonhomme; Rosa Infante; Fanny Rosas; Esmelda Montalban; Jessica Rios; Julkanya Chokephaibulkit; Thanomsak Anekthananon; Jullapong Achalapong; Pacharee Kantipong; Guttiga Halue; Wirawan Rasri; Prapap Yuthavisuthi; Malee Techapornroong; Sinart Prommas; Prapaisri Layangool; Chureeratana Bowonwatanuwong; Nantasak Chotivanich; Fuanglada Tongprasert; Patcharaphan Sugandhavesa; Vanessa Cajahuaringa; Renee Weinman; Sara Mattiucci; Princy Kumar; Joseph Timpone; Chivon McMullen-Jackson; Shelley Buschur
1-Sep-2019Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy studyBeatriz Grinsztejn; Michael D. Hughes; Justin Ritz; Robert Salata; Peter Mugyenyi; Evelyn Hogg; Linda Wieclaw; Robert Gross; Catherine Godfrey; Sandra W. Cardoso; Aggrey Bukuru; Mumbi Makanga; Sharlaa Faesen; Vidya Mave; Beatrice Wangari Ndege; Sandy Nerette Fontain; Wadzanai Samaneka; Rode Secours; Marije van Schalkwyk; Rosie Mngqibisa; Lerato Mohapi; Javier Valencia; Patcharaphan Sugandhavesa; Esmelda Montalban; Anchalee Avihingsanon; Breno R. Santos; Nagalingeswaran Kumarasamy; Cecilia Kanyama; Robert T. Schooley; John W. Mellors; Carole L. Wallis; Ann C. Collier; B. Grinsztejn; P. N. Mugyenyi; A. Collier; R. Salata; C. Godfrey; E. Hogg; M. Hughes; J. Ritz; L. Wieclaw; T. Sise; J. W. Mellors; C. Wallis; C. V. Fletcher; M. Gandhi; R. Gross; R. T. Schooley; R. Walensky; M. van Schalkwyk; S. Faesen; R. Mngqibisa; J. Valencia; E. Montalban; N. Kumarasamy; C. Kanyama; S. W. Cardoso; B. R. Santos; B. Mansfield; H. Mugerwa; B. W. Ndege; R. Secours; W. Samaneka; D. Kadam; V. Mave; M. Makanga; S. N. Fontain; P. Sugandhavesa; A. Avihingsanon; L. Nakibuuka; H. Nassolo; P. Anthony; V. Kulkarni; M. Nsubuga; J. van Wyk; J. Rooney; Y. van Delft; R. Leavitt; R. Luk; A. Benns; L. Hovind; A. Shahkolahi
1-Jun-2022Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trialAnchalee Avihingsanon; Michael D. Hughes; Robert Salata; Catherine Godfrey; Caitlyn McCarthy; Peter Mugyenyi; Evelyn Hogg; Robert Gross; Sandra W. Cardoso; Aggrey Bukuru; Mumbi Makanga; Sharlaa Badal-aesen; Vidya Mave; Beatrice Wangari Ndege; Sandy Nerette Fontain; Wadzanai Samaneka; Rode Secours; Marije Van Schalkwyk; Rosie Mngqibisa; Lerato Mohapi; Javier Valencia; Patcharaphan Sugandhavesa; Esmelda Montalban; Cornelius Munyanga; Maganizo Chagomerana; Breno R. Santos; Nagalingeswaran Kumarasamy; Cecilia Kanyama; Robert T. Schooley; John W. Mellors; Carole L. Wallis; Ann C. Collier; Beatriz Grinsztejn
Showing results 1 to 10 of 10